Search

everythinglearnresearchcommunity

for

Search:↓

CD2 might be a new treatment target for patchy alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Azathioprine may help treat severe alopecia areata, but more research is needed.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.